Howard W. Robin

2009

In 2009, Howard W. Robin earned a total compensation of $3M as President and Chief Executive Officer at Nektar Therapeutics, a 20% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,000,000
Option Awards$1,257,743
Salary$730,417
Other$14,973
Total$3,003,133

Robin received $1.3M in option awards, accounting for 42% of the total pay in 2009.

Robin also received $1M in non-equity incentive plan, $730.4K in salary and $15K in other compensation.

Rankings

In 2009, Howard W. Robin's compensation ranked 1,531st out of 9,885 executives tracked by ExecPay. In other words, Robin earned more than 84.5% of executives.

ClassificationRankingPercentile
All
1,531
out of 9,885
85th
Division
Manufacturing
540
out of 3,690
85th
Major group
Chemicals And Allied Products
107
out of 871
88th
Industry group
Drugs
69
out of 643
89th
Industry
Pharmaceutical Preparations
56
out of 446
87th
Source: SEC filing on April 30, 2012.

Robin's colleagues

We found two more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2009.

2009

John Nicholson

Nektar Therapeutics

Chief Financial Officer

2009

Gil Labrucherie

Nektar Therapeutics

General Counsel

News

You may also like